458 related articles for article (PubMed ID: 24072041)
1. Glucosamine hydrochloride exerts a protective effect against unilateral ureteral obstruction-induced renal fibrosis by attenuating TGF-β signaling.
Park J; Lee SY; Ooshima A; Yang KM; Kang JM; Kim YW; Kim SJ
J Mol Med (Berl); 2013 Nov; 91(11):1273-84. PubMed ID: 24072041
[TBL] [Abstract][Full Text] [Related]
2. HuangQi Decoction Ameliorates Renal Fibrosis via TGF-β/Smad Signaling Pathway In Vivo and In Vitro.
Zhao J; Wang L; Cao AL; Jiang MQ; Chen X; Wang Y; Wang YM; Wang H; Zhang XM; Peng W
Cell Physiol Biochem; 2016; 38(5):1761-74. PubMed ID: 27161221
[TBL] [Abstract][Full Text] [Related]
3. Apamin inhibits renal fibrosis via suppressing TGF-β1 and STAT3 signaling in vivo and in vitro.
Gwon MG; An HJ; Gu H; Kim YA; Han SM; Park KK
J Mol Med (Berl); 2021 Sep; 99(9):1265-1277. PubMed ID: 34031696
[TBL] [Abstract][Full Text] [Related]
4. Heat shock protein 90 inhibitor attenuates renal fibrosis through degradation of transforming growth factor-β type II receptor.
Noh H; Kim HJ; Yu MR; Kim WY; Kim J; Ryu JH; Kwon SH; Jeon JS; Han DC; Ziyadeh F
Lab Invest; 2012 Nov; 92(11):1583-96. PubMed ID: 22964853
[TBL] [Abstract][Full Text] [Related]
5. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
[TBL] [Abstract][Full Text] [Related]
6. Renal fibrosis is not reduced by blocking transforming growth factor-β signaling in matrix-producing interstitial cells.
Neelisetty S; Alford C; Reynolds K; Woodbury L; Nlandu-Khodo S; Yang H; Fogo AB; Hao CM; Harris RC; Zent R; Gewin L
Kidney Int; 2015 Sep; 88(3):503-14. PubMed ID: 25760325
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro.
Wang L; Chi YF; Yuan ZT; Zhou WC; Yin PH; Zhang XM; Peng W; Cai H
Exp Biol Med (Maywood); 2014 Oct; 239(10):1310-24. PubMed ID: 24879422
[TBL] [Abstract][Full Text] [Related]
8. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK
Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
[TBL] [Abstract][Full Text] [Related]
9. Biochanin A alleviates unilateral ureteral obstruction-induced renal interstitial fibrosis and inflammation by inhibiting the TGF-β1/Smad2/3 and NF-kB/NLRP3 signaling axis in mice.
Ram C; Gairola S; Syed AM; Kulhari U; Kundu S; Mugale MN; Murty US; Sahu BD
Life Sci; 2022 Jun; 298():120527. PubMed ID: 35378138
[TBL] [Abstract][Full Text] [Related]
10. Low-dose paclitaxel ameliorates renal fibrosis by suppressing transforming growth factor-β1-induced plasminogen activator inhibitor-1 signaling.
Jung ES; Lee J; Heo NJ; Kim S; Kim DK; Joo KW; Han JS
Nephrology (Carlton); 2016 Jul; 21(7):574-82. PubMed ID: 26869361
[TBL] [Abstract][Full Text] [Related]
11. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling.
Liu N; He S; Ma L; Ponnusamy M; Tang J; Tolbert E; Bayliss G; Zhao TC; Yan H; Zhuang S
PLoS One; 2013; 8(1):e54001. PubMed ID: 23342059
[TBL] [Abstract][Full Text] [Related]
12. Intermedin is upregulated and attenuates renal fibrosis by inhibition of oxidative stress in rats with unilateral ureteral obstruction.
Qiao X; Wang L; Wang Y; Zhao N; Zhang R; Han W; Peng Z
Nephrology (Carlton); 2015 Nov; 20(11):820-31. PubMed ID: 26014968
[TBL] [Abstract][Full Text] [Related]
13. Preventive effects and mechanisms of rhein on renal interstitial fibrosis in obstructive nephropathy.
He D; Lee L; Yang J; Wang X
Biol Pharm Bull; 2011; 34(8):1219-26. PubMed ID: 21804209
[TBL] [Abstract][Full Text] [Related]
14. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of TGF-β1-receptor posttranslational core fucosylation attenuates rat renal interstitial fibrosis.
Shen N; Lin H; Wu T; Wang D; Wang W; Xie H; Zhang J; Feng Z
Kidney Int; 2013 Jul; 84(1):64-77. PubMed ID: 23486519
[TBL] [Abstract][Full Text] [Related]
16. Vitamin E ameliorates renal fibrosis by inhibition of TGF-beta/Smad2/3 signaling pathway in UUO mice.
Tasanarong A; Kongkham S; Duangchana S; Thitiarchakul S; Eiam-Ong S
J Med Assoc Thai; 2011 Dec; 94 Suppl 7():S1-9. PubMed ID: 22619900
[TBL] [Abstract][Full Text] [Related]
17. MFAP4 deficiency alleviates renal fibrosis through inhibition of NF-κB and TGF-β/Smad signaling pathways.
Pan Z; Yang K; Wang H; Xiao Y; Zhang M; Yu X; Xu T; Bai T; Zhu H
FASEB J; 2020 Nov; 34(11):14250-14263. PubMed ID: 32905637
[TBL] [Abstract][Full Text] [Related]
18. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis.
Li YK; Ma DX; Wang ZM; Hu XF; Li SL; Tian HZ; Wang MJ; Shu YW; Yang J
Pharmacol Res; 2018 May; 131():102-111. PubMed ID: 29530599
[TBL] [Abstract][Full Text] [Related]
19. Endophilin A2 protects against renal fibrosis by targeting TGF-β/Smad signaling.
Mai X; Shang J; Chen Q; Gu S; Hong Y; Zhou J; Zhang M
FASEB J; 2022 Nov; 36(11):e22603. PubMed ID: 36259445
[TBL] [Abstract][Full Text] [Related]
20. Integrin-mediated type II TGF-β receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling.
Chen X; Wang H; Liao HJ; Hu W; Gewin L; Mernaugh G; Zhang S; Zhang ZY; Vega-Montoto L; Vanacore RM; Fässler R; Zent R; Pozzi A
J Clin Invest; 2014 Aug; 124(8):3295-310. PubMed ID: 24983314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
